Background
Segerdahl Corporation, a direct-mail printing company founded in 1956, was wholly owned by its employee stock ownership plan (ESOP) following its creation in 2003. Bruce Rush served as the company’s vice president of manufacturing and held shares in the ESOP. In 2015, facing liquidity concerns from anticipated stock redemptions as aging shareholders retired, Segerdahl’s Board decided to explore a sale. The company retained JP Morgan to run an auction process, with instructions to focus on financial buyers (private equity firms) rather than strategic buyers (competitors).
Four private equity firms participated in bidding. After due diligence, ICV emerged as the final bidder and submitted a revised offer of $250 million with a $15 million earnout. Following aggressive negotiations led by JP Morgan, ICV increased its offer to $265 million in cash with no earnout in October 2016. GreatBanc, the ESOP’s trustee, obtained fairness opinions from its advisors Stout Risius Ross (valuation firm) and Drinker Biddle & Reath (legal counsel). Both advisors concluded the $265 million price was adequate. The GreatBanc Fiduciary Committee approved the transaction, and the sale closed on December 7, 2016. Senior managers, including Rush, received substantial cash payments upon closing through the exercise of stock appreciation rights (SARs).
Dissatisfied with the sale price, Rush sued GreatBanc, Segerdahl’s board members Richard Joutras and Mary Lee Schneider, and outside directors Bob Cronin, Rod Goldstein, and Peter Mason. Rush alleged they breached their ERISA fiduciary duties by deliberately depressing the sale price. He claimed defendants excluded strategic buyers, resumed negotiations with only ICV, and improperly disclosed confidential valuations to manipulate the bidding process. After a three-week bench trial, the district court ruled for all defendants.
The Court’s Holding
The Seventh Circuit affirmed the district court’s judgment in favor of defendants on all counts. The panel held that the abuse-of-discretion standard of review applies to ERISA fiduciary decisions absent a conflict of interest, even when all plan participants share aligned economic interests. The court rejected Rush’s argument that plenary review should apply because every ESOP shareholder wanted the highest possible sale price. Under settled trust law principles and the ESOP plan document’s grant of “sole and absolute discretion” to the administrator, deference to fiduciary judgment is appropriate.
Examining each alleged breach, the court found no clear error in the district court’s findings. Regarding the exclusion of strategic buyers, the court credited defendants’ testimony that Quad/Graphics and RR Donnelley were unlikely bidders due to financial constraints and concerns about disclosing competitively sensitive information to competitors during diligence. Rush’s theory that defendants depressed the price to benefit themselves failed because defendants’ SAR values were directly tied to the sale price, aligning their interests with the ESOP’s. The court also found no clear error in defendants’ decision to reengage with ICV after its lowered offer, rejecting Rush’s speculation about personal tax liability motivation. Regarding alleged improper disclosures of valuations and bidder status, the court deferred to the district court’s factual findings that these disclosures were reasonable business judgments. Finally, the court affirmed that Rush failed to prove damages and that no ERISA prohibited transactions occurred.
Key Takeaways
- ERISA fiduciary decisions receive deferential abuse-of-discretion review absent a conflict of interest, applying established trust law principles even when plan participants have uniform economic interests.
- An ESOP trustee does not breach fiduciary duties by excluding potential bidders from a sales process where the excluded bidders face documented financial or practical obstacles to completing a transaction.
- Fiduciaries’ decisions to disclose valuation information or negotiate with a single bidder during a transaction are reviewed for abuse of discretion and do not necessarily constitute breach where business justifications support the decisions.
- Alignment of individual fiduciaries’ economic interests with the plan (through mechanisms like SARs) supports the inference that fiduciaries acted to maximize value rather than depress price for improper personal benefit.
Why It Matters
This decision provides significant guidance on the scope of judicial review for ERISA fiduciary conduct in complex ESOP transactions. By confirming the application of abuse-of-discretion review even when all plan participants share identical economic interests, the court clarifies that fiduciaries retain substantial discretion in conducting sales processes. The ruling protects ESOP trustees and boards from liability for transaction decisions that lack obvious conflicts of interest, provided the decision-making process was informed and the fiduciaries obtained competent advice.
The decision also has practical implications for ESOP sales processes. It validates the use of focused bidding processes (such as targeting only financial buyers), the reliance on professional advisors’ fairness opinions, and the negotiation tactics employed in attempting to maximize price. For shareholders dissatisfied with transaction outcomes, the ruling establishes a high bar for challenging ERISA fiduciary conduct—merely disagreeing with the process or outcome, or pointing to evidence of alternative strategies, does not establish clear error under the deferential standard of review applied by courts of appeals to factual findings at trial.